Pulse Biosciences (PLSE)
(Delayed Data from NSDQ)
$17.87 USD
-0.86 (-4.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $17.89 +0.02 (0.11%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Pulse Biosciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 1 | 1 | 0 | 0 |
Cost Of Goods | 0 | 12 | 2 | 0 | 0 |
Gross Profit | 0 | -11 | -1 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 47 | 62 | 50 | 48 |
Income After Depreciation & Amortization | -44 | -58 | -63 | -50 | -48 |
Non-Operating Income | 1 | 0 | -1 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -42 | -59 | -64 | -50 | -47 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -42 | -59 | -64 | -50 | -47 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -42 | -59 | -64 | -50 | -47 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -42 | -57 | -62 | -49 | -47 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -44 | -58 | -63 | -50 | -48 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.04 | 33.94 | 27.96 | 23.25 | 20.75 |
Diluted EPS Before Non-Recurring Items | -0.85 | -1.65 | -2.24 | -2.14 | -2.26 |
Diluted Net EPS (GAAP) | -0.88 | -1.72 | -2.28 | -2.14 | -2.26 |
Fiscal Year end for Pulse Biosciences, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 11.73 | 10.61 | 12.53 | 11.25 | 10.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | -11.73 | -10.61 | -12.53 | -11.25 | -10.23 |
Non-Operating Income | 0.34 | 0.48 | 0.60 | 0.69 | 0.32 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -11.38 | -10.14 | -11.93 | -10.57 | -9.91 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -11.38 | -10.14 | -11.93 | -10.57 | -9.91 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -11.38 | -10.14 | -11.93 | -10.57 | -9.91 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 55.17 | 55.06 | 54.92 | 44.51 |
Diluted EPS Before Non-Recurring Items | NA | -0.17 | -0.21 | -0.19 | -0.21 |
Diluted Net EPS (GAAP) | -0.20 | -0.18 | -0.21 | -0.19 | -0.22 |